Search - tctmd.com

Displaying 681 - 700 of 2362

Sort: Relevancy | Date

Presentation TCT 2024

TCT 656: Integral iFR

Presenter: Stanislav Pekarskiy

October 29, 2024

Presentation TCT 2024

TCT 644: Burden of Non-Rheumatic Calcific Aortic Valve Disease and Non-Rheumatic Degenerative Mitral Valve Disease in High-Income North America and West Europe From 1990 to 2021

Presenter: Vidit Majmundar

October 29, 2024

Presentation TCT 2024

TCT 642: Pre-Procedural Factors Contributing to the Difference in Time to TAVR and SAVR

Presenter: Curtiss Stinis

October 29, 2024

Presentation TCT 2024

TCT 640: Temporal Trends in Calcified Aortic Valve Disease-related Mortality in Canada Over the Past 30 Years

Presenter: Zaid Abdulelah

October 29, 2024

Presentation TCT 2024

TCT 270: Contemporary Use of Mechanical Circulatory Support for the Treatment of Acute Myocardial Infarction Cardiogenic Shock (AMI-CS): Insights From the BMC2 Registry

Presenter: Eric Cantey

October 29, 2024

Presentation TCT 2024

TCT 269: Insights From the Danger-SHOCK and ECLS-Shock Trials: A Comparative Analysis

Presenter: Giuseppe Tarantini

October 29, 2024

Presentation TCT 2024

TCT 268: Comparison of In-Hospital Outcomes and Patterns of Mechanical Circulatory Support for Patients With Cardiogenic Shock Transferred for Impella Support vs Those With In-House Support

Presenter: Karnav Modi

October 29, 2024

Presentation TCT 2024

TCT 127: Thirty-Day High-Grade AV Block Post Transcatheter Aortic Valve Replacement in Patients Discharged on Heart Rhythm Monitor

Presenter: Mohamad Saleh Alabdaljabar

October 29, 2024

Presentation TCT 2024

TCT 126: Anticoagulation Therapy in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Presenter: Koki Takegawa

October 29, 2024

Presentation TCT 2024

TCT 125: Predictors of Pathological Electrophysiological Study Post-TAVI: Focusing on Changes in PR and QRS Intervals

Presenter: Paula Vela Martin

October 29, 2024

Presentation TCT 2024

TCT 123: Is HV Interval Prior TAVR a Stronger Predictor for Permanent Pacemaker Implantation Than CT Anatomic Features?

Presenter: José Antonio Baz Alonso

October 29, 2024

Presentation TCT 2024

TCT 122: Perioperative and In-Hospital Outcomes of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample 2016-2021

Presenter: Ankur Singla

October 29, 2024

Presentation TCT 2024

TCT 1017: First-in-Human Intracoronary Structural-Molecular Imaging for Multi-Targeted Characterization of High-Risk Plaques in Patients With Coronary Artery Disease

Presenter: Dong Oh Kang

October 29, 2024

Presentation TCT 2024

TCT 1016: Targeted Intravascular Photoactivation Guided by Multimodal OCT-NIRF Imaging on Atherosclerotic Plaque

Presenter: Jin Hyuk Kim

October 29, 2024

Presentation TCT 2024

TCT 1015: Cryotherapy for Vulnerable Plaque Stabilization: Preliminary Report From Polarstar: A First-In-Human Study

Presenter: Bouisset Frederic

October 29, 2024

Presentation TCT 2024

TCT 1014: Lipid-Rich Non-Culprit Lesions Demonstrate Less Favorable Changes in Plaque Volume During the First Weeks After ACS

Presenter: Jonathan Los

October 29, 2024

Presentation TCT 2024

TCT 1013: Predictors of Cardiac Events from Vulnerable Coronary Plaque: Insight From PREVENT Trial

Presenter: Seong-Bong Wee

October 29, 2024

Presentation TCT 2024

TCT 1012: Pre-Emptive PCI in Vulnerable Coronary Plaques Reduces Biomechanical and Anatomic High-Risk Features: The PROSPECT ABSORB Trial

Presenter: Diaa Hakim

October 29, 2024

Presentation TCT 2024

Topic 4: Strategies to Improve T-TEER Imaging Guidance and Procedural Flow

Presenter: Anna Sannino

October 29, 2024

Presentation TCT 2024

Topic 3: Assessment of T-TEER Results and Intra-Procedural Outcomes

Presenter: Edwin Ho

October 29, 2024

Advertisement

TCT 656: Integral iFR

TCT 644: Burden of Non-Rheumatic Calcific Aortic Valve Disease and Non-Rheumatic Degenerative Mitral Valve Disease in High-Income North America and West Europe From 1990 to 2021

TCT 642: Pre-Procedural Factors Contributing to the Difference in Time to TAVR and SAVR

TCT 640: Temporal Trends in Calcified Aortic Valve Disease-related Mortality in Canada Over the Past 30 Years

TCT 270: Contemporary Use of Mechanical Circulatory Support for the Treatment of Acute Myocardial Infarction Cardiogenic Shock (AMI-CS): Insights From the BMC2 Registry

TCT 269: Insights From the Danger-SHOCK and ECLS-Shock Trials: A Comparative Analysis

TCT 268: Comparison of In-Hospital Outcomes and Patterns of Mechanical Circulatory Support for Patients With Cardiogenic Shock Transferred for Impella Support vs Those With In-House Support

TCT 127: Thirty-Day High-Grade AV Block Post Transcatheter Aortic Valve Replacement in Patients Discharged on Heart Rhythm Monitor

TCT 126: Anticoagulation Therapy in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Replacement

TCT 125: Predictors of Pathological Electrophysiological Study Post-TAVI: Focusing on Changes in PR and QRS Intervals

TCT 123: Is HV Interval Prior TAVR a Stronger Predictor for Permanent Pacemaker Implantation Than CT Anatomic Features?

TCT 122: Perioperative and In-Hospital Outcomes of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the National Inpatient Sample 2016-2021

TCT 1017: First-in-Human Intracoronary Structural-Molecular Imaging for Multi-Targeted Characterization of High-Risk Plaques in Patients With Coronary Artery Disease

TCT 1016: Targeted Intravascular Photoactivation Guided by Multimodal OCT-NIRF Imaging on Atherosclerotic Plaque

TCT 1015: Cryotherapy for Vulnerable Plaque Stabilization: Preliminary Report From Polarstar: A First-In-Human Study

TCT 1014: Lipid-Rich Non-Culprit Lesions Demonstrate Less Favorable Changes in Plaque Volume During the First Weeks After ACS

TCT 1013: Predictors of Cardiac Events from Vulnerable Coronary Plaque: Insight From PREVENT Trial

TCT 1012: Pre-Emptive PCI in Vulnerable Coronary Plaques Reduces Biomechanical and Anatomic High-Risk Features: The PROSPECT ABSORB Trial

Topic 4: Strategies to Improve T-TEER Imaging Guidance and Procedural Flow

Topic 3: Assessment of T-TEER Results and Intra-Procedural Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content